Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on IUGR in New Zealand
Total 0 results
Nothing found
Sponsors and Collaborators
Chengdu Integrated TCM&Western Medicine Hospital
Intermed Hospital
French National Society of Gastroenterology
African Institute for Health and Development
Sysmex Inostics GmbH
Brandeis University
Chul Kim
metaMe Health
Klinikum Freising
ATTRaCT program by A*STAR BMRC Singapore
R.Bos
Jennifer King
Meyer Children's Hospital, Florence, Italy
CEVAC Core Lab, University Ghent
Seed Health
Menzis
Creighton University
Bioraba
Zhengzhou First People's Hospital
Kyongtae Ty Bae, M.D., Ph.D.
View Full List
Medical Conditions
Bleeding at Gastric Cancer
Regenerative Periodontal Treatment
Chronic Myeloid Leukemia Blast Crisis (CML-BC, Ph+)
Alert Fatigue, Health Personnel
Plaque Type Psoriasis
Root Canal Sealers
Abdominal Aortic Aneurysm >= 5.5 Centimeters in Male (Disorder)
Bacterial Reduction Post-product Application
Adductor Pollicis
Mild Traumatic Brain Injury; Concussion
Early Phase of Severe Sepsis and Septic Shock
B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma
Value-Based Health Insurance
Failure; Cardiac
Parenteral Iron Therapy
Cell Phone Use
Chronic Hepatitis C Virus Infection
Systemic Lupus Erythematosus Nephritis
Burn Wound and Skin Graft Healing
Hearing Loss, Bilateral or Unilateral
View Full List
Drug Interventions
0.27 mg/kg, age≥65
Methylphenidate
Leucovorin
Esketamine
Follitropin beta liquid formulation
Phase 2a, SQY51 (cohort 3)
Itraconazole
30 mg CVL-231 Target Release, Fed
Galantamine CR
Bupivacaine 0.5%
Stem Cell Product
Nitric Oxide gas at 160ppm
Insulin glargine
PF-06650833
Ciclesonide
IDP-126 Vehicle Gel
Fesoterodine
LFG316 active drug
Soy protein isolate
Estradiol plus MPA
View Full List
CROs by country
Contract Research Organizations in Algeria
Contract Research Organizations in Brazil
Contract Research Organizations in Canada
Contract Research Organizations in Costa Rica
Contract Research Organizations in Ghana
Contract Research Organizations in Guinea
Contract Research Organizations in Jamaica
Contract Research Organizations in Liberia
Contract Research Organizations in Malaysia
Contract Research Organizations in Nigeria
Contract Research Organizations in Slovenia
Contract Research Organizations in Venezuela
Contract Research Organizations in Vietnam
CRO list by country
CROs in Uganda
SGS
Dokumeds
MCT
MRC/UVRI Uganda Research Unit
ACROSS Global
All CROs in Uganda
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe